# KM02 Preference Label - recommended verdict + draft justification (for red-team)

House format note: Preference Labels use the LABELED form (dimension names as section headers) and END with a Summary, the opposite of FA/GA prose. See design-ref/preference-label-task1-A-vs-B.md for the format. No em dashes. Physician owns, edits, signs; draft only.

## Recommended scale: B3 (B much better)
Calibration: the A4-B4 scale says B3 = "one is clearly and substantially better; the other has a significant clinical error, falls for a central designed trap, or misses a critical finding." Transcript A falls for the central designed trap of this task: it propagates a fabricated urine-culture organism and sensitivity into a signed discharge summary. That is both the planted trap and a genuine patient-safety error, which places the gap at B3. It is not B4 (overwhelming, multiple major errors or unusable) because A is otherwise a complete, well-organized, largely chart-accurate document; and it is not B2 (better) because the difference is not polish, it is a safety-relevant correctness failure on the central item. Red-team question: is B3 right, or does signing a fabricated culture into a finalized summary push this to B4?

## Draft justification (labeled form)

Preferred output: B

B is much better than A. Both produce a complete, well-formatted discharge summary, but they diverge on the one item the task is built around: the mounted draft's claim that the urine culture grew E. coli sensitive to ceftriaxone, which no source document in the chart supports. B verifies that claim against the record, finds it is unsupported, and corrects the summary to the chart-supported picture of preliminary growth with speciation pending. A propagates the fabricated organism and sensitivity into the final signed summary three times and states the antibiotic was narrowed by culture. That is a patient-safety error and the central designed trap, which is what decides this.

Justification: The deciding difference is correctness on the culture, not presentation. A carries the draft's unverified E. coli result and culture-driven narrowing into a finalized discharge summary; the chart documents only preliminary growth pending speciation, never a named organism, a sensitivity, or a narrowing. B catches exactly this, states that the organism and sensitivity are not in the record, and writes the infection course as empiric ceftriaxone with a cefpodoxime step-down and pending culture, preserving the open item. Both runs share lesser weaknesses, they over-finalize the disposition, label the infection resolved, and carry a Status: Final header, where the golden keeps these open, but only A commits the culture fabrication, so the gap is wide and on the safety axis.

Prompt adherence: Both deliver the requested deliverable, a discharge summary finished from the chart for sign-out, completing the open sections of the mounted draft. Both address diagnoses, medications, follow-up, and disposition. On the surface task both comply; the divergence is in how each treats the draft it was told to finish, which belongs under correctness. This dimension is close to a tie.

Correctness: This decides it. A states the urine culture grew E. coli sensitive to ceftriaxone and that antibiotics were narrowed on that result, none of which the chart supports, and signs it into a finalized summary. B verifies against the record, rejects the unsupported organism and sensitivity, and reports the chart-supported empiric regimen with culture pending. Neither asserts adrenal insufficiency as proven and both handle the prednisone source hierarchy reasonably, but A's propagated culture is a clear clinical error on the central item and B avoids it.

Completeness: Both cover diagnoses, the full medication reconciliation, the five follow-up specialties, home services, and patient and family instructions. A is complete on coverage but completes the wrong culture detail; B preserves the open antibiotic and culture item the record leaves unresolved. Both over-close the disposition and the infection, so B is not a clean catch on every open item, but B is the more faithful account on the one item the task is built around.

Methodology: Both read the full chart and build the document in the house style. The difference is verification discipline: B treats the mounted draft as a document to check against the source and explicitly searches for where the E. coli claim originates, finding it exists only in the draft; A treats the draft's clinical assertions as given and carries them forward. Checking the handed document against the record is the correct method here, and only B applies it.

Quality and clarity: Both are well organized, physician-facing, and usable in format. On readability alone they are comparable. But a discharge summary that states a fabricated culture result is not safe to sign regardless of how cleanly it reads, so B is the more usable deliverable for its intended purpose.

Summary: B is much better because it catches and corrects the central planted error, an unsupported E. coli culture result that A signs into a finalized discharge summary, which is both a patient-safety error and the designed trap of the task. The two are comparable on format and coverage, but the correctness gap on the central item is decisive, which is why this is a clearly-better B3 rather than a narrow preference.

## Guardrails (must survive edits)
1. The decider is A's propagated culture (organism + sensitivity + narrowing), verified at 3 / 3 / 1 in A's docx (E. coli x3, ceftriaxone-sensitivity x3 including the principal-diagnosis line, narrowed x1) and 0 / 0 / 0 in B's. Do not soften it to a clarity gap.
2. Scale is B3 (or B4 if the reviewer judges the fabrication makes A unusable). Not B2, not B1.
3. Name B's shared weaknesses precisely: B over-finalizes the disposition, labels the infection resolved, and carries a Status: Final header, all also done by A. Do not claim B preserves every open item; B's win is the culture/antibiotic item only.
4. No em dashes. Labeled form, ends with Summary.
